(TC67) Adjunctive Use of Botulinum Toxin A in Endodontic Practice for Non-Odontogenic Pain Management

Abstract: The realm of endodontics has traditionally been confined to the diagnosis and treatment of odontogenic pain originating from the pulp and periapical tissues. However, non-odontogenic facial pain poses a diagnostic and therapeutic challenge, often persisting despite optimal endodontic therapy. The objective of this presentation is to elucidate the use of Botulinum Toxin A (BoNT-A) among endodontists as a supplementary treatment modality for non-odontogenic pain, potentially expanding the scope of endodontics. BoNT-A is an acetylcholine release inhibitor and neuromuscular blocking agent, providing long-lasting muscle relaxation effects that have become increasingly popular to treat a wide assortment of orofacial issues ranging from chronic migraines to temporomandibular disorders. Future trends of BoNT-A application in endodontic offices will depend on the indications of BoNT-A treatment for non-odontogenic pain among patients undergoing root canal therapy. Additionally, endodontists should be willing to incorporate BoNT-A into practice as well as receive educational training on BoNT-A administration. In conclusion, BoNT-A may be beneficial in managing non-odontogenic facial pain that often coexists with odontogenic discomfort, enhancing the skills of endodontists by improving comprehensive patient care and opening avenues for multidisciplinary collaboration in pain management.